A Translational Approach to Gitelman Syndrome
Sponsor: Oregon Clinical and Translational Research Institute
Listed as NCT00822107, this NA trial focuses on Gitelman Syndrome and remains completed. Sponsored by Oregon Clinical and Translational Research Institute, it has been updated 9 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
May 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — May 2019 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oregon Clinical and Translational Research Institute
- Oregon Health and Science University
For direct contact, visit the study record on ClinicalTrials.gov .